• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure.

作者信息

Modica Jessica, Di Mauro Vittoria, Barandalla-Sobrados Maria, Chavez Samuel Elias Pineda, Carullo Pierluigi, Nemska Simona, Anselmo Achille, Condorelli Gianluigi, Iafisco Michele, Miragoli Michele, Catalucci Daniele

机构信息

National Research Council-Institute of Genetics and Biomedical Research, Milan Unit, Italy (J.M., V.D.M., M.B.-S., P.C., G.C., M.M., D.C.).

Humanitas University, Pieve Emanuele (Milan), Italy (G.C., J.M.).

出版信息

Circulation. 2021 Dec 14;144(24):1973-1976. doi: 10.1161/CIRCULATIONAHA.121.055866. Epub 2021 Dec 13.

DOI:10.1161/CIRCULATIONAHA.121.055866
PMID:34898244
Abstract
摘要

相似文献

1
Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure.纳米 miR-133a 替代疗法可减轻压力超负荷诱导的心力衰竭。
Circulation. 2021 Dec 14;144(24):1973-1976. doi: 10.1161/CIRCULATIONAHA.121.055866. Epub 2021 Dec 13.
2
Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy.靶向心肌细胞中高丰度的环状 RNA circSlc8a1 可减轻压力超负荷诱导的心肌肥厚。
Cardiovasc Res. 2019 Dec 1;115(14):1998-2007. doi: 10.1093/cvr/cvz130.
3
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.微小RNA-99a的过表达减轻心脏肥大。
PLoS One. 2016 Feb 25;11(2):e0148480. doi: 10.1371/journal.pone.0148480. eCollection 2016.
4
Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36.心肌细胞特异性 miR-100 过表达可保护小鼠在压力超负荷下的心脏功能，并通过直接抑制 Nox4 和 CD36 减少脂肪酸摄取和 ROS 产生。
FASEB J. 2021 Nov;35(11):e21956. doi: 10.1096/fj.202100829RR.
5
Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure.miR-148a 的治疗性传递抑制心力衰竭中的心室扩张。
Mol Ther. 2019 Mar 6;27(3):584-599. doi: 10.1016/j.ymthe.2018.11.011. Epub 2018 Nov 17.
6
Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure.药理学沉默 microRNA-152 可预防压力超负荷诱导的心力衰竭。
Circ Heart Fail. 2020 Mar;13(3):e006298. doi: 10.1161/CIRCHEARTFAILURE.119.006298. Epub 2020 Mar 12.
7
Inhibition of miR-25 improves cardiac contractility in the failing heart.抑制 miR-25 可改善心力衰竭心脏的收缩功能。
Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12.
8
MicroRNAs: new players in heart failure.微小 RNA：心力衰竭的新角色。
Mol Biol Rep. 2013 Mar;40(3):2663-70. doi: 10.1007/s11033-012-2352-y. Epub 2012 Dec 15.
9
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.miR-133和miR-30调控结缔组织生长因子：微小RNA在心肌基质重塑中的作用
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178. doi: 10.1161/CIRCRESAHA.108.182535. Epub 2008 Dec 18.
10
MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats.微小RNA-133a通过抑制心力衰竭大鼠的Akt改善心脏功能和纤维化。
Biomed Pharmacother. 2015 Apr;71:185-9. doi: 10.1016/j.biopha.2015.02.030. Epub 2015 Mar 3.

引用本文的文献

1
Mechanical response microRNA-145a-5p alleviates osteoarthritis by inhibiting inflammation and promoting chondrogenesis.机械响应性微小RNA-145a-5p通过抑制炎症和促进软骨形成来减轻骨关节炎。
PeerJ. 2025 Aug 19;13:e19905. doi: 10.7717/peerj.19905. eCollection 2025.
2
Cardiovascular inhalation for targeted drug delivery in cardiac disease.用于心脏病靶向药物递送的心血管吸入法。
Heart Fail Rev. 2025 May 23. doi: 10.1007/s10741-025-10527-w.
3
Intratracheal Delivery of a Phospholamban Decoy Peptide Attenuates Cardiac Damage Following Myocardial Infarction.
气管内递送磷蛋白诱饵肽可减轻心肌梗死后的心脏损伤。
Int J Mol Sci. 2025 Mar 14;26(6):2649. doi: 10.3390/ijms26062649.
4
Recent Advances in Aptamers-Based Nanosystems for Diagnosis and Therapy of Cardiovascular Diseases: An Updated Review.基于适配体的纳米系统在心血管疾病诊断与治疗中的最新进展：综述更新
Int J Nanomedicine. 2025 Feb 25;20:2427-2443. doi: 10.2147/IJN.S507715. eCollection 2025.
5
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs.一种使用人外周血单核细胞对纳米配方靶向兰尼碱受体2（RyR2）的小干扰RNA（siRNA）药物进行体外测试和危害评估的新方法。
Life (Basel). 2025 Jan 14;15(1):95. doi: 10.3390/life15010095.
6
The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.肌微RNA-133a-3p、-133b和-206失调在心血管疾病风险中的潜在作用
Int J Mol Sci. 2024 Nov 27;25(23):12772. doi: 10.3390/ijms252312772.
7
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice.可吸入心脏靶向肽修饰的纳米药物可预防雄性小鼠的压力超负荷性心力衰竭。
Nat Commun. 2024 Jul 18;15(1):6058. doi: 10.1038/s41467-024-50312-1.
8
Diagnostic and Therapeutic Aptamers: A Promising Pathway to Improved Cardiovascular Disease Management.诊断和治疗性适体：改善心血管疾病管理的一条充满希望的途径。
JACC Basic Transl Sci. 2023 Sep 27;9(2):260-277. doi: 10.1016/j.jacbts.2023.06.013. eCollection 2024 Feb.
9
Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis.非编码核糖核酸作为心肌纤维化的诊断和治疗靶点。
Curr Heart Fail Rep. 2024 Jun;21(3):262-275. doi: 10.1007/s11897-024-00653-1. Epub 2024 Mar 15.
10
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician.血管系统中血流反应性非编码RNA：临床医生的基础机制
J Clin Med. 2022 Jan 17;11(2):459. doi: 10.3390/jcm11020459.